Sáez-Llorens, Xavier <br/><br/>
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.  [electronic resource] 

 -  The Pediatric infectious disease journal  Aug 2004 
 - 707-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0891-3668 
<br/><br/><label>Standard No.: </label>10.1097/01.inf.0000133165.85909.08  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antiviral Agents--adverse effects<br/>Child<br/>Child, Preschool<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Infant<br/>Infusions, Intravenous<br/>Male<br/>Palivizumab<br/>Placebos<br/>Respiratory Syncytial Virus Infections--drug therapy<br/>Treatment Outcome